Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Survey on Hypertension in Cardiologic Private Practice (Prophyl C)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00695175
Recruitment Status : Completed
First Posted : June 11, 2008
Last Update Posted : August 6, 2009
Sponsor:
Information provided by:
AstraZeneca

Brief Summary:
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in private cardiology consultation by holding account of type of exercise of the cardiologist (private exclusive or mixed hospital and private).

Condition or disease
Hypertension

Layout table for study information
Study Type : Observational
Actual Enrollment : 1800 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Profile of Hypertensive Patients Seen in Private Cardiology Consultation
Study Start Date : February 2008
Actual Study Completion Date : September 2008

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Demographic, clinical and health care characteristics [ Time Frame: Once ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
First three consecutive patients with hypertension seen by Cardiologists
Criteria

Inclusion Criteria:

  • male or female > or = 18 years old
  • Known hypertension
  • agree to take part in this study

Exclusion Criteria:

  • none

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00695175


Locations
Show Show 436 study locations
Sponsors and Collaborators
AstraZeneca
Investigators
Layout table for investigator information
Study Director: Alain Castaigne, Medical Director AstraZeneca

Layout table for additonal information
Responsible Party: Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00695175    
Other Study ID Numbers: NIS-CFR-DUM-2007/6
First Posted: June 11, 2008    Key Record Dates
Last Update Posted: August 6, 2009
Last Verified: August 2009
Keywords provided by AstraZeneca:
Hypertension
Private cardiology consultation
Patients with hypertension
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertension
Vascular Diseases
Cardiovascular Diseases